Senate2025-26 sessionFiscal note
ESSB 5916 — Concerning nonopioid drugs for the treatment of pain.
Did not pass — the 2025–26 session has ended
- Sponsor
- Harris
- Introduced
- January 27, 2026
- Status
- S Rules 3
- Last action
- By resolution, returned to Senate Rules Committee for third reading. (March 12, 2026)
Floor votes
- Senate — 3rd Reading & Final Passage · February 11, 202649 yea · 0 nay
Track ESSB 5916 on OlympiaTrack
A free account adds a plain-English AI summary, the full hearing and amendment record, who testified, and roll calls by member. Track the subject and get an alert if it comes back next session.
Create a free accountOther bills sponsored by Harris
- SSB 5316 — Modifying provisions of the revised uniform unclaimed property act.
- SSB 5370 — Lengthening port commissioner terms.
- SB 5455 — Concerning the administration of the Andy Hill cancer research endowment.
- 2ESSB 5594 — Concerning biosimilar medicines. (REVISED FOR ENGROSSED: Concerning biosimilar medicines and interchangeable biological products.)
- ESSB 5628 — Concerning lead in cookware.
All 2025-26 Washington State bills →
Source: the Washington State Legislature. OlympiaTrack is an independent bill-tracking service and is not affiliated with the Legislature. View on leg.wa.gov ↗